Non-invasive liquid biopsy test for early-stage prostate cancer detection using glycan analysis in blood serum. Achieves up to 90% accuracy using magnetic particle-based technology with minimal blood sample requirement of 10 microliters.
Manufactured by
Bratislava, Slovakia
At Glycanostics, our aim is to develop, clinically validate register an affordable, non-invasive next-gen liquid biopsy prostate cancer diagnostic test with accuracy of up to 90%.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
HLB PANAGENE Co., Ltd.
South Korea · 2 relevant products
Singlera GENOMICS (SHANGHAI) Ltd.
China · 6 relevant products
guangzhou biotron technolongy co.,ltd
China · 2 relevant products
FLIM LABS SRL
Italy · 2 relevant products
Biomerica, Inc.
United States · 1 relevant product
STRATEC/Diatron
Germany · 1 relevant product
i Med Laboratories Co., Ltd.
Thailand · 1 relevant product
Berkeley Health Ltd
United Kingdom · 2 relevant products
Zhejiang QL Biotech Co., Ltd.
China · 1 relevant product
PRIMA Lab SA
Switzerland · 1 relevant product
49 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 95 closest product alternatives
HLB PANAGENE Co., Ltd. · South Korea
A liquid biopsy diagnostic test for detection of EGFR mutations in circulating tumor DNA, supporting non-invasive lung cancer monitoring and treatment selection.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A liquid biopsy-based test utilizing DNA methylation markers for post-treatment cancer recurrence monitoring and surveillance. Enables early detection of disease relapse and progression.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A molecular diagnostic test utilizing DNA methylation technology for early detection of lung cancer. Enables risk assessment and early diagnosis of lung malignancies through liquid biopsy methodology.
guangzhou biotron technolongy co.,ltd · China
Liquid biopsy assay for real-time monitoring of circulating tumor markers and cells during perioperative periods to assess surgical outcomes and recurrence risk.
FLIM LABS SRL · Italy
A nanoparticle-enabled blood test utilizing biophotonic technology for early detection of pancreatic ductal adenocarcinoma. The test aims to identify pancreatic cancer at earlier stages, potentially improving patient survival rates significantly compared to conventional diagnostic methods.
Biomerica, Inc. · United States
An advanced diagnostic test for prostate cancer screening. Designed as an at-home screening product targeting high-prevalence cancer detection.
STRATEC/Diatron · Germany
In-vitro diagnostic test for detecting tumor markers and cancer-related antigens in blood and other biological samples. The test aids in cancer screening, diagnosis, and treatment monitoring.
i Med Laboratories Co., Ltd. · Thailand
Diagnostic test for detection of cancer biomarkers in blood and body secretions. Identifies biomolecules produced and released by cancer cells for screening and monitoring purposes.
Berkeley Health Ltd · United Kingdom
Rapid home test kit for semi-quantitative detection of prostate-specific antigen in human whole blood. Enables self-screening for prostate health status with results available within 15 minutes. ISO 13485:2016 certified for accuracy and reliability.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A DNA methylation-based molecular diagnostic test designed for early detection and risk assessment across multiple cancer types. The test utilizes proprietary methylation technology to identify cancer signals in biological samples.
Zhejiang QL Biotech Co., Ltd. · China
PRIMA Lab SA · Switzerland
Self-test for the detection of the Prostate-Specific Antigen (PSA) in whole blood samples
83 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products